BAIM INSTITUTE FOR CLINICAL RESEARCH INC (EIN 043521077) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

MICHAEL GIBSON MD

Phone

6173075200

Tax Period

2023-10-01 to 2024-09-30

BAIM INSTITUTE FOR CLINICAL RESEARCH INC, founded in 2000, is a mid-sized nonprofit in the Medical Research sector that reported $19.0M in total revenue in fiscal year 2023. Revenue surged 40% from the prior year, signaling strong growth momentum. The organization ran a surplus of $5.0M, a strong 27% operating margin.

Mission

TO ENGAGE IN AND FACILITATE SCIENTIFIC AND MEDICAL RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $18,370,543

Investment Income $434,228

Other Revenue $155,752

TOTAL REVENUE $18,960,523

Expense Breakdown

Grants Paid $0

Salaries & Benefits $8,883,080

Fundraising Expenses $0

Program Expenses $13,584,360

Other Expenses $5,041,068

TOTAL EXPENSES $13,924,148

Year-over-Year Comparison

	2023	2022	Change
Revenue	$18,960,523	$13,536,792	+0.4%
Expenses	$13,924,148	$13,305,828	+0.0%
Net Income	$5,036,375	$230,964	+20.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$3,236,090

Total Directors

$4,839,450

Key Employees

$982,820

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SZABO MD PHD HON GYONGYI	TTEE (EX-OFF); (CAO, BIDMC & BILH)	1.00	Director	$0	$89,291	$1,102,496
GIBSON MD MICHAEL	TRUSTEE (EX-OFFICIO) & PRESIDENT	30.00	Officer Director	$430,000	$85,530	$1,030,292
ZEIDEL MD MARK L	TTEE (EX-O)/CHAIR; (CHIEF MED BIDMC)	1.00	Officer Director	$0	$87,340	$979,372
GERSZTEN MD ROBERT	TTEE (EXOFF)(CHIEF,BIDMC CARDIO MED)	1.00	Director	$0	$42,355	$721,623
AGNEW MEGHAN	TTEE (EX OFFICIO) & TREAS; CFO, HFMP	1.00	Officer Director	$0	$89,105	$518,759
MERSKI CARA	TTEE (EXOFF);BILH DEP COMPLIANCE OFF	1.00	Director	$0	$40,704	$285,380
COLOZZO MEGHAN	TTEE (EXO) (DIR, COMPL & PRIV, BILH)	1.00	Director	$0	$14,345	$201,528
ARMSTRONG ESQ EMILY	CLERK (EXO); DIV VP DEP GC BOS, BILH	1.00	Officer	$0	$41,550	$351,216
FRITZ SUE	SR. DIRECTOR, FINANCE	55.00	Officer	$208,738	$22,191	$230,929
HALPRIN VICTORIA	DIRECTOR, FINANCE	55.00	Officer	$117,652	$7,870	$125,522
FRIZZELL CHARLES	EVP, BUSINESS OPS (END 9/20/23)	55.00	Key Emp	$286,526	$11,131	$297,657
CHEN XIAOHUA	DIRECTOR OF BIOSTATS	55.00	Key Emp	$240,194	$9,600	$249,794
WEDGE PATRICIA	CHIEF OPERATING OFFICER	55.00	Key Emp	$207,292	$28,698	$235,990
PECJO BRIAN	DIRECTOR, INFORMATION TECHNOLOGY	55.00	Key Emp	$176,805	$22,574	$199,379
THUM CLAUDIA	DIRECTOR, PROJECT MANAGEMENT	55.00	Highest	$160,698	$25,585	$186,283
IVANOVA ALLA	DIRECTOR, DATA MANAGEMENT	55.00	Highest	$146,762	$33,073	$179,835
AMMU SONIA T	DIRECTOR, CLINICAL OPERATIONS	55.00	Highest	$164,673	$6,923	$171,596
SULLIVAN GAIL	DIRECTOR OF HUMAN RESOURCES	55.00	Highest	$145,206	$15,838	$161,044
THIIRAH KELLY	DIRECTOR, CONTRACTS	55.00	Highest	$137,140	$18,011	$155,151
FREEDMAN MD STEVEN	FRMR TTEE & CHAIR (PHYSICIAN, BIDMC)	0.00		$0	$64,211	$600,162

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$18,960,523	$13,924,148	$30,238,751	$5,036,375
2023	$13,536,792	$13,305,828	$26,425,573	$230,964
2022	$14,165,368	$12,404,724	$20,688,470	$1,760,644
2020	$17,724,993	$15,058,395	$19,935,879	$2,666,598
2019	$17,860,063	$15,190,589	$15,548,353	$2,669,474
2018	$20,185,448	$17,220,636	$15,315,526	$2,964,812

BAIM INSTITUTE FOR CLINICAL RESEARCH INC